Frontlight ResearchEarly access
Trial site
Jefferson City Medical Group
- 6running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes4 trials
- High blood pressure3 trials
- Childhood cancers1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Obesity1 trial
- Rheumatoid arthritis1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 24 trials
- Phase 32 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting2 trials
- Suspended1 trial
- Lead sponsor
- Novartis Pharmaceuticals2 trials
- Boehringer Ingelheim1 trial
- DexCom, Inc.1 trial
- Eli Lilly and Company1 trial
- Fractyl Health Inc.1 trial
- and 4 more
Running trials
Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Active, not recruiting
Recruiting
Active, not recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Active, not recruiting
CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin
Active, not recruiting
A Study of AL102 in Patients With Progressing Desmoid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure2 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Baricitinib in Participants With Rheumatoid Arthritis
Site data: ClinicalTrials.govUpdated 17 Nov 2026